Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 9

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 9
---
 proxy voting instructions but do not direct how your shares should be voted on each item,                           
 the persons named as proxies will vote your shares in the manner recommended by Aadi’s board of directors on all matters presented in this proxy statement. The persons named as proxies will vote on any other matters properly presented at the        
 Special Meeting in accordance with their best judgment, although we have not received timely notice of any other matters that may be properly presented for voting at the Special Meeting.                                                               |
| Voting Results                |     | We will announce preliminary results at the Special Meeting. We will report final results by filing a Form 8-K within four business days after the Special Meeting. If final results are not available at that time, we will                             
 provide preliminary voting results in the Form 8-K and will provide the final results in an amendment to the Form 8-K as soon as they become available.                                                                                                  |
| Additional Solicitation/Costs |     | Our board of directors is soliciting proxies for use at the Special Meeting by means of the proxy materials. We will bear the entire cost of the distribution of the proxy statement and our proxy materials and solicitation                            
 of the proxies. As part of this process, we reimburse brokerage houses and other custodians, nominees and fiduciaries for their reasonable out-of-pocket expenses for forwarding proxy and solicitation materials to our beneficial stockholders. Proxy  
 solicitation expenses that we will pay include those for preparation, mailing, returning and tabulating the proxies. Our directors, officers, and employees may also solicit proxies on our behalf in person, by telephone, email or facsimile, but they 
 do not receive additional compensation for providing those services.                                                                                                                                                                                     |

- 4 -

QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING, VOTING AND THE PROPOSALS What proposals are the Aadi stockholders being asked to vote on at the Special Meeting? At the Special Meeting, our stockholders will consider and vote on the following matters:

| 1. | Divestiture Proposal. To approve the sale by Aadi to KAKEN INVESTMENTS INC. (“Kaken”) of 100%                                                                                                                                                     
 of the outstanding shares of capital stock of Aadi Subsidiary, Inc. (“Aadi Sub”) and thereby all or substantially all of Aadi’s assets related to its FYARRO® (sirolimus                                                                          
 protein-bound particles for injectable suspension) (albumin-bound) program (the “FYARRO Business”), pursuant to the terms of